Reaffirming the preemptive authority of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) and the Public Health Service Act (42 U.S.C. 201 et seq.) (including regulations thereunder) with respect to State laws that inhibit access to or use of any reproductive health product.
In Congress· Pursuant to the provisions of H. Res. 1529, H. Res. 1434 is considered passed House.
Introduced
Oct 14, 22
Passed House
Dec 21, 22
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending
Introduced
Oct 14, 22
Passed House
Dec 21, 22
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending
No roll call votes have been recorded for this bill.